search

PubMed Search Builder

Matrix Metalloproteinase Inhibitors [Pharmacological Action]

Tree Number(s): D061965
MeSH Unique ID: D061965
Entry Terms:
  • (diethyl((methylsulfinyl)methyl)phosphonate)(dimethylmalonato)platinum(II) (Supplementary Concept)
  • (R)-2-(4'-bromo-biphenyl-4-sulfonyl-amino)-3-methyl-butyric acid (Supplementary Concept)
  • 1-benzyl-4-(4-(4-chlorophenoxy)benzenesulfonyl)piperidine-4-carboxylic acid (Supplementary Concept)
  • 1-cyclopropyl-N-hydroxy-4-(4-(4-(trifluoromethoxy)phenoxy)phenylsulfonyl)piperidine-4-carboxamide (Supplementary Concept)
  • 2'-fluoro-6,7-methylenedioxy-2-phenyl-4-quinolone (Supplementary Concept)
  • 2-((4-biphenylsulfonyl)amino)-3-phenylpropionic acid (Supplementary Concept)
  • 2-(4'-methoxybiphenyl-4-sulfonylamino)-3-methylbutyric acid (Supplementary Concept)
  • 2-(4-(but-2-ynyloxy)phenylsulfonamido)-3-(1-(4-methoxybenzyl)-1H-indol-3-yl)propanoic acid (Supplementary Concept)
  • 2-(4-hydroxy-3-methyl-2-butenyl)hydroquinone (Supplementary Concept)
  • 2-(8-(methoxycarbonylamino)dibenzo(b,d)furan-3-sulfonamido)-3-methylbutanoic acid (Supplementary Concept)
  • 2-(biphenyl-4-ylsulfonyl)-1,2,3,4-tetrahydroisoquinolin-3-carboxylic acid (Supplementary Concept)
  • 3,4,5-trihydroxybenzaldehyde (Supplementary Concept)
  • 3-(((2,2-dimethyl-1-(((2-methoxy-1-phenylethyl)amino)carbonyl)propyl)amino)carbonyl)-6-(3-methyl-4-phenylphenyl)hexanoic acid (Supplementary Concept)
  • 3-((benzyl)(methylaminocarbonyl)methylaminocarbonyl)N-hydroxy-5-methylhexanamide (Supplementary Concept)
  • 3-methyl-2-(4-(3-p-tolyl(1,2,4)oxadiazol-5-yl)benzenesulfonylamino)butyric acid (Supplementary Concept)
  • 4-(4-(4-fluorophenoxy)benzenesulfonylamino)tetrahydropyran-4-carboxylic acid hydroxyamide (Supplementary Concept)
  • 4-(carboxy-(5-(4'-ethoxyphenyl)thiophene-2-sulfonylamino)methyl)piperidine-1-carboxylic acid isopropyl ester (Supplementary Concept)
  • 4-des-dimethylaminotetracycline (Supplementary Concept)
  • 4-methyl-1-((5-((3-oxo-3,4-dihydro-2H-benzo(1,4)oxazin-6-ylmethyl)carbamoyl)pyrazolo(1,5-a)pyrimidine-7-carbonyl)amino)indan-5-carboxylic acid (Supplementary Concept)
  • 5-aza-6-cyclohexylmethyl-3-cyclohexylpropyl-4,7-dioxo-7-(phenylethylamino)heptanohydroxamic acid (Supplementary Concept)
  • 5-aza-6-cyclohexylmethyl-4,7-dioxo-7-(phenylethylamino)-3-phenylpropylheptanohydroxamic acid (Supplementary Concept)
  • 5-methyl-2-(4-methylphenyl)-1H-benzimidazole (Supplementary Concept)
  • 6-(4-(4-imidazol-1-ylphenoxy)benzenesulfonyl)-4,5,6,7-tetrahydrofuro(2,3-c)pyridine-5-carboxylic acid (Supplementary Concept)
  • AZD3342 (Supplementary Concept)
  • BB87 collagenase inhibitor (Supplementary Concept)
  • cadin-2-en-1-ol-1-glucuronopyranoside (Supplementary Concept)
  • CGS 27023 (Supplementary Concept)
  • CH1766 (Supplementary Concept)
  • CH6631 (Supplementary Concept)
  • CL82198 (Supplementary Concept)
  • CT 1418 (Supplementary Concept)
  • dichloro(diethyl((methylsulfinyl)methyl)phosphonate)platinum(II) (Supplementary Concept)
  • funalenone (Supplementary Concept)
  • L 758354 (Supplementary Concept)
  • LY52 compound (Supplementary Concept)
  • MAG 283 (Supplementary Concept)
  • matlystatin A (Supplementary Concept)
  • matlystatin B (Supplementary Concept)
  • matlystatin D (Supplementary Concept)
  • matlystatin E (Supplementary Concept)
  • matlystatin F (Supplementary Concept)
  • methyl 6-(benzyloxycarbonylamino)-2-(2-(2,6-dioxo-3-(3,4,5-trimethoxybenzamido)piperidin-1-yl)acetamido)hexanoate (Supplementary Concept)
  • N(4)-(2,2-dimethyl-1-methylcarbamoylpropyl)-N(1)-hydroxy-2-hydroxymethyl-3-(4-methoxyphenyl)succinamide (Supplementary Concept)
  • N(4)-(2,2-dimethyl-1-methylcarbamoylpropyl)-N(1)-hydroxy-2-hydroxymethyl-3-phenylsuccinamide (Supplementary Concept)
  • N-(2(R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl)-L-tryptophan methylamide (Supplementary Concept)
  • N-(2-isobutyl-3-(N'-hydroxycarbonylamido)propanoyl)-O-methyltyrosinemethylamide (Supplementary Concept)
  • N-(3-N-(benzyloxycarbonyl)amino-1-carboxypropyl)leucyl-O-methyltyrosine N-methylamide (Supplementary Concept)
  • N-alpha-(4-(2-phenyl-2H- tetrazole-5-yl) phenyl sulfonyl)-D-tryptophan (Supplementary Concept)
  • N-benzyloxycarbonyl-prolyl-alanyl-3-amino-2-oxopropyl-leucyl-alanyl-glycine ethyl ester (Supplementary Concept)
  • N-biphenylsulfonylphenylalanine hydroxamic acid (Supplementary Concept)
  • N-hydroxy-1-(2-methoxyethyl)-4-((4-(4-(trifluoromethoxy)phenoxy)phenyl)sulfonyl)piperidine-4-carboxamide (Supplementary Concept)
  • N-hydroxy-2-(((4'-methoxyphenyl)sulfonyl)benzylamino)-3-methylbutanamide (Supplementary Concept)
  • N-hydroxy-2-(4-methoxybenzenesulfonyl)-2-methyl-3-(4-(2-piperidin-1-ylethoxy)phenyl)propionamide (Supplementary Concept)
  • N-hydroxy-2-(N-isopropoxybiphenyl-4-ylsulfonamido)-3-methylbutanamide (Supplementary Concept)
  • N-hydroxy-4-((4-(4-(trifluoromethyl)phenoxy)phenyl)sulfonyl)tetrahydro-2H-pyran-4-carboxamide (Supplementary Concept)
  • N-hydroxy-4-((4-(phenylthio)phenyl)sulfonyl)-1-(2-propynyl)-4-piperidinecarboxamide (Supplementary Concept)
  • N-hydroxy-4-((4--methoxyphenyl)sulfonyl)-2,2-dimethylhexahydro-1,4-thiazepine-3-carboxamide 1,1-dioxide (Supplementary Concept)
  • N-hydroxy-4-((4-methoxyphenyl)sulfonyl)-2,2-dimethylhexahydro-1,4-thiazepine-3-carboxamide (Supplementary Concept)
  • N-hydroxy-5-ethoxymethyloxy-2-methyl-4-(4-phenoxybenzoyl)aminopentanamide (Supplementary Concept)
  • N2-(2-((hydroxycarbamoyl)methyl)-4-methylvaleryl)-N1,3-dimethylvalinamide (Supplementary Concept)
  • OSU8 1 (Supplementary Concept)
  • PD 180557 (Supplementary Concept)
  • PF152 compound (Supplementary Concept)
  • PGE 1132881 (Supplementary Concept)
  • phthaloyl-glycyl(P)-isoleucyl-tryptophyl-benzylamide (Supplementary Concept)
  • PNU 107859 (Supplementary Concept)
  • PNU 141803 (Supplementary Concept)
  • PNU 142372 (Supplementary Concept)
  • prinomastat (Supplementary Concept)
  • Ro 26-2812 (Supplementary Concept)
  • Ro 32-3555 (Supplementary Concept)
  • RXP 409 (Supplementary Concept)
  • RXP470.1 peptide (Supplementary Concept)
  • S 3304 (Supplementary Concept)
  • saucerneol G (Supplementary Concept)
  • SCH 43534 (Supplementary Concept)
  • SI 27 (Supplementary Concept)
  • SM 7368 (Supplementary Concept)
  • Tissue Inhibitor of Metalloproteinase-1 (MeSH Term)
  • Tissue Inhibitor of Metalloproteinase-2 (MeSH Term)
  • Tissue Inhibitor of Metalloproteinase-3 (MeSH Term)
  • Tissue Inhibitor of Metalloproteinases (MeSH Term)
  • triazin 17-2 (Supplementary Concept)
  • YL 01869P (Supplementary Concept)
  • YLL 224 (Supplementary Concept)
  • zincov (Supplementary Concept)

Comments (0)

No login
gif